Core Viewpoint - The Shanghai Stock Exchange has decided to terminate the review of Qingdao Gulf Chemical Co., Ltd.'s initial public offering (IPO) and listing on the Shanghai Main Board due to the company's withdrawal of its application [1][3]. Group 1: Company Background - Qingdao Gulf Chemical's main business includes chlor-alkali chemicals, organic chemical raw materials, polymer new materials, and inorganic silicon products, with key products such as PVC, styrene, polystyrene, and caustic soda [3]. - The controlling shareholder of Gulf Chemical is Qingdao Gulf Group Co., Ltd., which holds 62% of the company's shares. The actual controller is the Qingdao State-owned Assets Supervision and Administration Commission through its ownership of Qingdao Investment [3]. Group 2: IPO Details - Gulf Chemical initially planned to issue no more than 25,344,990 shares, accounting for no more than 15% and no less than 10% of the total share capital after issuance [4]. - The company aimed to raise 300 million yuan for various projects, including a green circular economy project for epoxy chloropropane, an epoxy resin project, and an expansion project for ethylene oxychlorination [4][6]. - The total investment for the planned projects is approximately 460.69 million yuan, with specific allocations for each project detailed in the funding table [6].

股票简称：华之杰 股票代码：603400 苏州华之杰电讯股份有限公司 Suzhou Huazhijie Telecom Co., Ltd. （江苏省苏州市吴中区胥口镇孙武路 1031 号） 首次公开发行股票主板上市公告书 保荐人（主承销商） （住所：北京市朝阳区安立路 66 号 4 号楼） 二〇二五年六月十九日 苏州华之杰电讯股份有限公司 上市公告书 特别提示 苏州华之杰电讯股份有限公司（以下简称"发行人"、"华之杰"、"本 公司"或"公司"）股票将于 2025 年 6 月 20 日在上海证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在 新股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 本上市公告书中若出现总数与各分项数值之和尾数不等的情况，均为四舍 五入尾差所致。 苏州华之杰电讯股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真 实、准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏， 并依法承担法律责任。 上海证券交易所、有关政府机关对本公司股票上市及有关事项的 ...

山东信通电子股份有限公司 首次公开发行股票并在主板上市 网上路演公告 本次发行的招股意向书全文及相关资料可在中国证监会指定的网站（巨潮资 讯网，网址 www.cninfo.com.cn；中证网，网址 www.cs.com.cn；中国证券网，网 址 www.cnstock.com；证券时报网，网址 www.stcn.com；证券日报网，网址 www.zqrb.cn）查阅。 敬请广大投资者关注。 本次发行采用向参与战略配售的投资者定向配售（以下简称"战略配售"）、 网下向符合条件的投资者询价配售（以下简称"网下发行"）与网上向持有深圳市 场非限售 A 股股份和非限售存托凭证市值的社会公众投资者定价发行（以下简 称"网上发行"）相结合的方式进行。 发行人和保荐人（主承销商）招商证券股份有限公司（以下简称"保荐人（主 承销商）"或"招商证券"）将通过网下初步询价直接确定发行价格，网下不再进 行累计投标询价。 本次拟公开发行股票 3,900.00 万股，占发行后公司总股本的 25.00%，全部 为公开发行新股，公司股东不进行公开发售股份。 本次发行初始战略配售数量为 780.00 万股，占本次发行数量的 20.00%。 ...

影石创新科技股份有限公司 扫描二维码查阅公告全文 首次公开发行股票科创板 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、 完整、及时，没有虚假记载、误导性陈述或重大遗漏。 上市公告书提示性公告 保荐人（联席主承销商） ：中信证券股份有限公司 联席主承销商：高盛（中国）证券有限责任公司 联席主承销商：中国国际金融股份有限公司 （三）股票代码：688775 （四）本次发行后的总股本：401,000,000 股 （五）本次公开发行的股票数量：41,000,000 股，且占发行后总股本的比例 为 10.22%，本次发行不涉及老股转让 二、风险提示 本公司提醒广大投资者注意首次公开发行股票（以下简称"新股"）上市初 期的投资风险，提醒广大投资者充分了解交易风险、理性参与新股交易，具体而 言，上市初期的风险包括但不限于以下几种： （一）涨跌幅限制放宽 根据《上海证券交易所交易规则》（2023 年修订），科创板股票交易实行价 格涨跌幅限制，涨跌幅限制比例为 20%。首次公开发行上市的股票上市后的前 5 个交易日不设价格涨跌幅限制。科创板股票存在股价波动幅度较剧烈的风险。 经上海证券交易所审核同意，影石创 ...

中国经济网北京6月5日讯科兴制药(688136.SH)昨晚发布股东减持股份计划公告。截至公告披露日，深 圳科益医药控股有限公司(以下简称"科益医药")直接持有科兴制药131,778,347股，占公司总股本的比例 为66.01%。科益医药直接持有的股份为其在公司首次公开发行前取得的股份，上述股份均已上市流 通。 科兴制药2020年以来3次分红合计派发现金红利5158.71万元。 科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200股，即不超过公 司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内(根据中国证券监督 管理委员会及上海证券交易所规定禁止减持的期间除外)进行。若减持计划实施期间公司发生送股、资 本公积金转增股本、配股等股份变动事项，将对拟减持股份数量和比例进行相应调整。 科兴制药2024年年度报告显示，深圳科益医药控股有限公司为公司控股股东，邓学勤为公司实际控制 人。 公司第二届董事会第二十二次会议审议通过《关于公司2024年度利润分配方案的议案》，公司2024年度 利润分配预案为：拟以实施权益分派股权登记日的总股本为基数，向全体股东按每 ...

Core Viewpoint - Haiyang Technology Co., Ltd. has successfully completed its initial public offering (IPO) and is set to list on the main board, with the issuance approved by the Shanghai Stock Exchange and registered by the China Securities Regulatory Commission [1][2]. Group 1: Issuance Details - The total number of shares for the IPO is 45.3129 million, with an initial strategic placement of 9.06258 million shares, accounting for 20% of the total issuance [2]. - The final issuance price is set at RMB 11.50 per share, with 1.45 million shares allocated for online pricing on June 3, 2025 [2]. - The issuance combines strategic placement, offline inquiry placement, and online issuance, with offline shares accounting for 60% and online shares for 40% of the total issuance after deducting the strategic placement [2][3]. Group 2: Subscription and Allocation - The initial effective subscription multiple for online issuance was approximately 6,633.72 times, leading to the activation of a reallocation mechanism [3]. - After the reallocation, the final number of offline shares issued is 724,982 shares, representing 20% of the total issuance after strategic placement [3]. - The final online winning rate for subscriptions is 0.03014953% [3]. Group 3: Strategic Placement Results - All investors participating in the strategic placement have fulfilled their subscription commitments, with a total of 9,062,580 shares allocated [6]. - The strategic placement results indicate that 90% of the shares will have no lock-up period, while 10% will be subject to a 6-month lock-up period starting from the listing date [5][6]. Group 4: Online Lottery Results - The online lottery for share allocation was conducted on June 4, 2025, with a total of 58,001 winning numbers announced [8]. - Each winning number can subscribe for 500 shares of Haiyang Technology [8]. Group 5: Offline Subscription Situation - The offline subscription process concluded on June 3, 2025, with 570 investors participating and a total of 7,967,890 shares effectively subscribed [9]. - The allocation results show that A-class investors received 5,076,952 shares, while B-class investors received 2,172,868 shares [10].

Core Viewpoint - Shenzhen Youyou Green Energy Co., Ltd. has successfully obtained approval for its initial public offering (IPO) and listing on the ChiNext board, with a total issuance of 10.5 million shares priced at RMB 89.60 per share [1][2]. Group 1: Issuance Details - The total number of shares for this issuance is 10.5 million, with a price of RMB 89.60 per share [1]. - The initial strategic placement consists of 2.1 million shares, accounting for 20% of the total issuance [2]. - The final strategic placement includes 948,659 shares allocated to senior management and core employees, representing 9.03% of the total issuance [2]. Group 2: Subscription and Allocation Mechanism - The issuance combines strategic placement, offline inquiries for qualified investors, and online pricing for public investors [2]. - After the strategic placement adjustment, the offline initial issuance is 6,082,681 shares (70.71%), while the online initial issuance is 2,520,000 shares (29.29%) [2]. - The final total issuance for both online and offline will be 8,602,681 shares, subject to adjustments based on the allocation mechanism [2]. Group 3: Payment and Trading Conditions - Investors must ensure sufficient funds in their accounts by May 28, 2025, to fulfill their subscription obligations [3][4]. - Shares from the public offering will be tradable on the Shenzhen Stock Exchange starting from the listing date [4][5]. - Offline investors are subject to a lock-up period of 6 months for 10% of their allocated shares, while 90% will have no restrictions [5]. Group 4: Subscription Statistics - The effective number of subscription accounts for the online offering reached 51,221,295, with a subscription multiple of 10,162.96 times [6][7]. - The final online subscription rate after the adjustment is set at 49.30% of the total issuance [7].

Core Viewpoint - Shandong Weigao Blood Purification Products Co., Ltd. has received approval for its initial public offering (IPO) of A-shares and will be listed on the main board, with the issuance price set at 26.50 yuan per share and a total of 41,139,407 shares to be issued [1][2]. Issuance Details - The IPO will consist of a combination of strategic placement, offline issuance, and online issuance, with the initial strategic placement amounting to 4,113,940 shares, representing 10% of the total issuance [1][2]. - The final strategic placement quantity was adjusted to 1,772,075 shares, approximately 4.31% of the total issuance, with the difference being allocated to offline issuance [2][3]. Subscription and Allocation - The offline issuance quantity after the strategic placement adjustment is 28,259,832 shares, accounting for 71.78% of the remaining shares, while the online issuance quantity is 11,107,500 shares, representing 28.22% [2][3]. - The initial effective subscription multiple for the online issuance was approximately 7,518.35 times, leading to the activation of the allocation mechanism, redistributing 15,747,000 shares from offline to online issuance [3]. Financial Statistics - The total amount raised from the online investors was approximately 707.77 million yuan, with 26,708,402 shares subscribed [8]. - The offline investors subscribed for 12,512,137 shares, totaling approximately 331.57 million yuan [8]. Underwriting and Fees - The total issuance costs are approximately 112.30 million yuan, including underwriting and advisory fees of 74.18 million yuan, audit and verification fees of 17.88 million yuan, and legal fees of 8.49 million yuan [10][11].

Group 1 - The core viewpoint of the report is that Guoyuan Securities Co., Ltd. has successfully completed the sponsorship and continuous supervision of Anhui Yuancheng Environmental Technology Co., Ltd.'s initial public offering (IPO) on the Sci-Tech Innovation Board [1][2] - Guoyuan Securities is responsible for the continuous supervision of Yuancheng Technology, which includes ensuring compliance with regulations and monitoring the company's internal control systems [2][3] - The IPO of Yuancheng Technology was completed on March 31, 2021, with a registered capital of 160 million yuan [1][2] Group 2 - During the due diligence phase, Guoyuan Securities conducted thorough investigations and prepared necessary documentation for the IPO, ensuring compliance with relevant regulations [1][2] - In the continuous supervision phase, the focus was on monitoring the company's operations, internal controls, and compliance with information disclosure obligations [2][3] - The company has established a system for information disclosure and has complied with relevant laws and regulations during the continuous supervision period [4][5] Group 3 - The report indicates that Yuancheng Technology has cooperated well with the sponsor, providing necessary information and documentation for the supervision process [3][4] - The securities service institutions hired by Yuancheng Technology performed their duties diligently and provided professional opinions and suggestions [4] - The management of raised funds has been compliant with regulations, and any issues identified have been rectified promptly [5]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、完整、及时，没有虚假记 载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，山东威高血液净化制品股份有限公司（以下简称"威高血净"、"发行 人"或"公司"）人民币普通股股票将于2025年5月19日在上海证券交易所主板上市，上市公告书全文和首 次公开发行股票的招股说明书全文披露于上海证券交易所网站（http://www.sse.com.cn/）和符合中国证 监会规定条件网站（中证网：http://www.cs.com.cn；中国证券网：http://www.cnstock.com；证券时报 网：http://www.stcn.com；证券日报网：http://www.zqrb.cn；经济参考网：http://www.jjckb.cn）披露，供 投资者查阅。 一、上市概况 本公司提醒广大投资者注意首次公开发行股票（以下简称"新股"）上市初期的投资风险，广大投资者应 充分了解风险、理性参与新股交易。具体如下： （一）涨跌幅限制放宽带来的股票交易风险 根据《上海证券交易所交易规则（2023年修订）》， ...